Chuck, I've seen multiple companies SP fall below CR price if your well experienced in ASX biotech you would know this is almost always the case.
All of which i have seen is now 50% to 850% higher today than time of CR.
For a company such as this establishing a financial threshold for future trials is pivotal for success, but I'm sure you know this.
Ann: Proposed issue of securities - IVX, page-8
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.63M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $10 | 5.237K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 48 | 35416379 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 7526664 | 44 |
View Market Depth
| Last trade - 15.59pm 01/11/2024 (20 minute delay) ? |
| IVX (ASX) Chart |